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fln{l{ARY
In th is thesis the rnetabol ic  pathways of  the new and very potent
D- 2 agonist  2 -  (N-propyl-N- 2 -  th ienylethylarnino) -  5 -hydroxyretra l in (N-
0437) have been invest igated in rats and nonkeys af ter  d i f ferent
dosing routes.  In addi t ion,  some bioanalyt ical  aspecÈs of  the drug
were studied in re laÈion to i ts  netabol ism. The drug was synthesized
at the Department of  Medic inal  Chemistry (Univ.  Center for  Pharmacy,
State Univers i ty ,  Groningen, The Nether lands) and i t  has potent ia l
appl icat ions in Parkinson's d isease,  schizophrenia and glaucoma.
Radioact ive exper iments were carr ied out  using I rH]  N-0437 wi th the
label  in the propyl  s ide chain.
P r i o r  co  t he  ne tabo l i sm  s tud ies  t he  phys Í co -chen i ca l  p rope r t i es
and the pur i ty  of  the parent  compound were assessed (chapter 2) .
I n  chapËe rs  3  and  4 ,  t he  me tabo l i c  f a t e  o f  N -0437  i n  r a t s  has  been
descr ibed,  af ter  int rawenous and oral  administrat ion.  Independent of
t he  dos ing  rou te ,  b i l e  p roved  t o  be  t he  ma in  r ou te  o f  exc re t i on ,
account ing for  about 90t  of  the dose administrated,  as compared to
about 10t  in the ur ine.  Drug metabol ic  prof i l ing revealed that  N-0437
r tas  a lmos t  comp le te l y  me tabo l i zed  p r i o r  t o  e l im ina t i on .  D i r ec t
glucuronidat íon at  the phenol ic  group is  the major  metabol i te,
accoun t i ng  f o r  50 t  ( i . v . )  o r  70 t  ( o ra l )  o f  t he  dose  adm in i sc ra ted .
ïh is metabol i te was detected in the bi le af ter  both dosing routes and
in the ur ine af ter  i .v .  dosing only.  The presence of  the glucuronide
in the ur ine af ter  oral  administrat ion was at t r ibuted to a gastro-
i n t es t i na l  f i r s t - pass  me tabo l i sm .  Hyd roxy la t i on  o f  N -0437  a t  t he
pos i t i on  o r t ho  t o  t he  pheno l i c  hyd roxy l ,  y i e l d i ng  6 -hyd roxy -N -0437
( N - 0 9 3 6 ) ,  a p p e a r e d  t o  a c c o u n t  f o r  a b o u t  1 3 t  ( i . v . )  o r  9 t  ( o r a l )  o f
the dose.  This catechol ic  interrnediate \ ras not  excreted as such,  but
was glucuronidated aË Ëhe 5 and 6-hydroxy posi t ions in about equal
amounts.  The di rect  sul fate conjugate of  N-0437 was v i r tual ly  absent
( 1 e s s  t h a n  0 . 2 t  o f  t h e  d o s e ) .
In order to carry out  metabol ism studíes in conscious monkeys,  a
method was developed which permit ted the col lect ion of  b i le ower a
p ro l onged  pe r i od  ( chap te r  5 ) .  Us ing  t h i s  t echn ique ,  t he  me tabo l i c
f ace  o f  N -0437  v ras  i nves t i ga ted  a f t e r  subsequen t  i . v . ,  o ra l  and
ocular  adrnin ist rat ion (chapters 6 and 7) .  In monkeys the
radioact iv i ty  was excreted to a larger extent  into the ur ine compared
to  r a t s .  A f t e r  o ra l  dos ing  65 t  was  recove red  i n  t he  b i l e  as  compared
to  30 t  i n  t he  u r i ne ,  wh i l e  a f t e r  i . v .  and  ocu la r  adm in i s t r a t i on  bo th
excret ion routes were of  about equal  inportance.  In a l l  excretory
f l u i ds ,  l ess  Èhan  0 .5 t  o f  t he  t o ta l  r ad ioac t i v i t y  cou ld  be  asc r i bed
to the parent  compound. Independent of  the dosing route,  the
glucuronide of  N-0437 was always a major  metabol i te,  account ing for
abou t  43 t  ( i . v .  and  ocu la r )  o r  72N  (o ra l )  o f  t he  dose .  The  f acË  t ha t
t he  g l ucu ron ide  i s  de tec ted  i n  monkey  u r i ne  a fËe r  i . v .
administrat ion,  in contrast  to the rat ,  could be explained by an
inter-species di f ference in renal  g lucuronidat ion act Ív i ty :  Monkey
renal  microsomes showed a glucuronyl t ransferase act iv i ty  towards N-
0437 ,  whereas rat  renal  microsornes did not  (chapter  8) .  The
sul foconjugate of  N-0437 proved to be present in monkey ur ine afÈer
i . v .  and  ocu la r  adm in i s t r a t i on .  Howeve r ,  a f t e r  o ra l  dos ing  t h i s
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virtual ly no sulfoconjugate was detected in the excrecory f luids.
Ihis incer-species dif ferencê may be attr ibuted to a dif ference ln
renal sulfotransferase activi ty Èo\íards N-0437, analogous to the
observed dif ferences in renal glucuronidation actlviËy. Hydroxylat ion
of N-0437 in the phenol r ing, yielding the intermediate N-0936,
comprised about 10t of the dose (excreted as the glucuronide) after
al l  three adninistrat lon routes. Monkeys expressed a clear
stereoselecÈive preference towards the glucuronidation of the
catechol at Ëhe 6-hydroxy posit ion.
In rats and monkeys the identi f ied netaboli tes conprised about 65t
of the dose after i .v. admlnistrat ion and 80t after oral dosing. ïhe
depropylat ion route could not yet be investigated due to the lack of
suitably labeled reference conpounds.
In vitro derlvatization of N-0437 with D(+) -glucuronic acid
resulted in the formation of two diastereoisomerlc glucuronides which
could be separated by a non-chiral chrornatographic system (chapter
9). The glucuronidation reaction could be ut i l ized to determine the
enantiomeric puri ty of the separate enantiomers because a
quantl tat ive derivatization was achieved within an acceptable
reaction t ine and no disturbance of the enantiomeric rat io was
observed (chapter  t0 ) .
In the netabolic prof i l ing studies a renarkably large dif ference
in elut ion behavior between the unlabeled uretabol i tes and their
tr iÈium labeled analogs was encountered. This could be ascribed tso a
phenomenon cal1ed isotopic separation. In chapter 11 this isotope
effect was studied and was deÍnonstrated to be pH dependent.
t l t_
